Suven Pharma stocks surge 5% after acquisition deal with Sapala Organics
The acquisition is expected to enhance Suven's technology platforms and strengthen its position in the rapidly growing nucleic acid-based therapy market14-06-2024
14-06-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation13-06-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Acquisition
Disclosure under Regulation 30 of the SEBI LODR regarding Acquisition13-06-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the management of the Company would be participating in various analyst/Institutional Investor meetings:06-06-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings conference call for the quarter and year ended March 31, 2024 conducted on May 30, 202404-06-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the management of the Company would be participating in the Ambit - Titans of Tomorrow Conference on Friday, June 07, 2024 Note: The schedule of the aforesaid meetings is subject to change. The change may happen due to exigencies on the part of Analyst / Institutional Investor / Company. No unpublished price-sensitive information will be shared during this interaction.31-05-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisiment regarding to Financial Results of the Company31-05-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of the earnings conference call for the quarter and year ended March 31, 202431-05-2024
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Acquisition
Outcome of the Board Meeting30-05-2024